12/04/2024 6:35 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 5:58 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:10 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:14 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 5:27 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024 7:00 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
10/31/2024 7:48 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024 8:15 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 5:26 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:20 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:30 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:32 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:33 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:40 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
09/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 5:03 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:07 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 6:06 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2024 5:23 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:31 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:22 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 5:51 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 5:19 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024 7:28 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024 7:35 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 5:15 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 5:13 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024 8:18 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. |
03/04/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/04/2024 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024 7:53 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024 7:55 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024 4:28 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 424B5 | |
02/15/2024 4:29 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/02/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024 7:39 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024 5:12 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/18/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/11/2024 4:19 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/11/2024 4:16 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2024 5:03 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 7:03 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 5:24 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 5:27 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024 7:04 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |